Brokers Set Expectations for Editas Medicine FY2026 Earnings
Editas Medicine, Inc. (NASDAQ:EDIT - Free Report) - Chardan Capital issued their FY2026 earnings estimates for Editas Medicine in a report released on Thursday, November 13th. Chardan Capital analyst Y. Livshits anticipates that the company will post earnings per share of ($1.41) for the year. Chard
Editas Medicine, Inc. (NASDAQ:EDIT - Free Report) - Chardan Capital issued their FY2026 earnings estimates for Editas Medicine in a report released on Thursday, November 13th. Chardan Capital analyst Y. Livshits anticipates that the company will post earnings per share of ($1.41) for the year. Chard
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
